Literature DB >> 3018820

Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review.

D M Gibbs.   

Abstract

ACTH secretion is primarily controlled by hypothalamic secretion of corticotropin releasing factor (CRF) into pituitary portal blood. However arginine vasopressin (AVP) and oxytocin (OT) can modulate the actions of CRF and at times may be important mediators of stress-induced ACTH secretion. The relative contributions of CRF, AVP, and OT to the control of ACTH secretion vary with different types of stress. In general, AVP stimulates ACTH secretion in all species studied. OT also stimulates ACTH release in rats but is inhibitory in primates. The involvement of AVP and OT in the control of ACTH secretion may have important implications for physiological and pathological conditions associated with activation of the hypothalamo--hypophysial--adrenal cortical axis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018820     DOI: 10.1016/0306-4530(86)90048-x

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  21 in total

1.  Diabetes increases the expression of hypothalamic neuropeptides in a spontaneous model of type I diabetes, the nonobese diabetic (NOD) mouse.

Authors:  F E Saravia; S L Gonzalez; P Roig; V Alves; F Homo-Delarche; A F De Nicola
Journal:  Cell Mol Neurobiol       Date:  2001-02       Impact factor: 5.046

2.  Oxytocin decreases colonic motility of cold water stressed rats via oxytocin receptors.

Authors:  Xiao Yang; Tao-Fang Xi; Yu-Xian Li; Hai-Hong Wang; Ying Qin; Jie-Ping Zhang; Wen-Ting Cai; Meng-Ting Huang; Ji-Qiao Shen; Xi-Min Fan; Xuan-Zheng Shi; Dong-Ping Xie
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  ACTH, cortisol and glucose responses after administration of vasopressin in cattle and sheep.

Authors:  M Senn; P M Maier; W Langhans
Journal:  J Comp Physiol B       Date:  1995       Impact factor: 2.200

4.  State of the vasopressin-, oxytocin-, and corticoliberin-synthesizing structures of the hypothalamus in experimental diabetes in rats of both sexes.

Authors:  A V Abramov
Journal:  Neurosci Behav Physiol       Date:  1994 Mar-Apr

5.  Effect of acute hypohydration on glycemic regulation in healthy adults: a randomized crossover trial.

Authors:  Harriet A Carroll; Iain Templeman; Yung-Chih Chen; Robert M Edinburgh; Elaine K Burch; Jake T Jewitt; Georgie Povey; Timothy D Robinson; William L Dooley; Robert Jones; Kostas Tsintzas; Widet Gallo; Olle Melander; Dylan Thompson; Lewis J James; Laura Johnson; James A Betts
Journal:  J Appl Physiol (1985)       Date:  2018-11-29

6.  Intranasal vasopressin affects pair bonding and peripheral gene expression in male Callicebus cupreus.

Authors:  M R Jarcho; S P Mendoza; W A Mason; X Yang; K L Bales
Journal:  Genes Brain Behav       Date:  2011-01-24       Impact factor: 3.449

7.  Involvement of cholecystokinin receptor types in pathways controlling oxytocin secretion.

Authors:  S M Luckman; M Hamamura; I Antonijevic; S Dye; G Leng
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

Review 8.  Seeing the unexpected: how sex differences in stress responses may provide a new perspective on the manifestation of psychiatric disorders.

Authors:  Laura Cousino Klein; Elizabeth J Corwin
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 9.  Molecular basis for the development of individual differences in the hypothalamic-pituitary-adrenal stress response.

Authors:  M J Meaney; S Bhatnagar; J Diorio; S Larocque; D Francis; D O'Donnell; N Shanks; S Sharma; J Smythe; V Viau
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

10.  Oxytocin does not attenuate the ex vivo production of inflammatory cytokines by lipopolysaccharide-activated monocytes and macrophages from healthy male and female donors.

Authors:  Kharah M Ross; Gaye McDonald-Jones; Gregory E Miller
Journal:  Neuroimmunomodulation       Date:  2013-07-27       Impact factor: 2.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.